Menopause Clinical Trial
Official title:
A New Hormone Replacement Paradigm: Physiologic Restoration Using Compounded Biomimetic Estradiol, Progesterone and Testosterone Applied Transdermally in a Rhythmic Dose
This is a three-year, prospective, observational study looking at the benefits of rhythmically dosed, bio-identical hormones compounded in a carrier cream in 100 symptomatic peri and postmenopausal women. This study will measure changes in cognition, mood, quality of life, endocrine health, bone mineral density, and reduction of the symptoms of menopause and any adverse effects. The objectives of this study are to show that rhythmic dosing of bio-identical hormones that mimic a menstrual cycle, are possible, and may be more beneficial and have fewer side effects than the current standard of care for treating the symptoms of menopause.
"Bio-identical" hormones, which are compounded plant-based hormones synthesized into
structurally similar to human estradiol and progesterone molecules, became popular in 2004 by
celebrity, Suzanne Somers, who let women know there were natural alternatives to the drugs
with hormone-like activity. Compounding hormones makes it easy to make dose adjustments in
order to manage symptoms. Using this form of hormone delivery, it is possible to try and
replicate a normal physiological reproductive pattern of replacement akin to thyroid
replacement, etc. Current short-term studies with bio- identical transdermal estradiol and
progesterone have not supported increased breast cancer or other issues such as venous
thrombosis7. Even the WHI stated that the increase in breast cancer was due to stimulation of
cancers already present.
This study of bio-identical physiologic restoration and dosing of estradiol, testosterone and
cyclical transdermal progesterone attempts to replicate the reproductive hormone patterns and
levels of a premenopausal woman. This dosing schedule has higher doses and levels than
current standard estradiol and progesterone hormone therapy for post menopause women.
Research shows that the estradiol peak of a menstrual cycle has an impact on cell signaling
and receptor response. For example, TP53, the gene major tumor suppressor gene is under
estrogen and progesterone control. At the peaks of estradiol and progesterone, TP53 is up
regulated conferring cellular protection against mutations8-14.
Physiologic Restoration (PR) with bio-identical rhythmic dosing was originally developed by
S.T. Wiley, who developed a template of hormone doses over time and was meant to be adjusted
to the individual women depending on their symptoms and, absorption, metabolism, and response
to the program. This study will utilize this concept with some improvements to the original
proposed template (Sex, Lies, and Menopause, 2004). This regimen has been in national
clinical practice since 2004 and has not been formally studied until now. There is
unpublished observational data from Dr. Taguchi's high risk population of oncology patients
(Santa Barbara Cottage Hospital IRB# 19-71ix) showing that PR is feasible and manages
menopause symptoms well without seemingly more adverse effects and better sense of well being
and excellent reversal or improvement of osteoporosis.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04553029 -
A Survey Evaluating Prevalence, Severity and Associated Factors in East Asian Women With Moderate-to-severe Menopause-related Vasomotor Symptoms (MR-VMS)
|
||
Completed |
NCT03672513 -
Short-term Supplementation, Bone Turnover and Antioxidant Status in Menopause
|
N/A | |
Terminated |
NCT03642119 -
Validation of an Objective Instrument to Measure Hot Flashes During Menopause
|
||
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04210583 -
RF and PEMF for Treatment of Vaginal Laxity and Mons Pubis and Labia for Improvement of Skin Laxity
|
N/A | |
Completed |
NCT06057896 -
Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
|
||
Completed |
NCT05617287 -
An Exploratory Investigation of Dietary Supplementation and the Effect on Common Symptoms of Perimenopause and Menopause
|
N/A | |
Recruiting |
NCT05180266 -
Therapeutic Touch and Music in The Menopausal Period
|
N/A | |
Recruiting |
NCT04043520 -
Bioenergetic Effects of Aging and Menopause (BEAM)
|
Phase 4 | |
Completed |
NCT03663075 -
Effect of Group Education and Individual Counselling on Mental Health and Quality of Life in 45-60 Year Old Women
|
N/A | |
Completed |
NCT03363997 -
Pharmacokinetics and Pharmacodynamics of 3 Dosages of Estriol After Continuous Vaginal Administration for 21 Days
|
Phase 1 | |
Not yet recruiting |
NCT04728126 -
Menopausal Symptoms and Burnout: Comparison of Occupational Health Issue Among Health Professionals in UMC Hospitals
|
||
Not yet recruiting |
NCT04724135 -
Assessment of Menopause Related Quality of Life Among Health Professionals in University Hospitals of UMC in Nur-Sultan
|
||
Completed |
NCT02274571 -
Raising Insulin Sensitivity in Post Menopause
|
Early Phase 1 | |
Completed |
NCT02430987 -
Low Sexual Desire and Metabolic Syndrome
|
N/A | |
Completed |
NCT02253173 -
Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women
|
Phase 3 | |
Completed |
NCT01757340 -
Calorie Restriction With Leucine Supplementation
|
N/A | |
Recruiting |
NCT01488903 -
A Cohort Research of Genetic Susceptibility for Common Obesity in Women
|
N/A | |
Terminated |
NCT01633814 -
Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women
|
N/A | |
Completed |
NCT00599456 -
Investigation of the Usefulness of Omega 3 Vitamins in the Relief of Hot Flashes in Menopausal Women.
|
N/A |